ClearSky Medical Diagnostics is attending and exhibiting at the 35th Global Conference of Alzheimer’s Disease International in June 2022.
The hybrid conference, which will be hosted online and in-person at The Kia Oval in London on 9 to 11 June 2022, has the theme of ‘new horizons in dementia’. In 2020, the conference attracted 1,600 delegates from 120 countries.
It will address the progress and barriers, new developments and innovations across all seven action areas of the WHO Global action plan on dementia. It will also look at recent developments and forecast breakthroughs in research, diagnosis, treatment, care and support.
After successfully launching two CE-marked intelligent devices for Parkinson’s, ClearSky is now working on a new product, MCI-Monitor™ for objectively detecting mild cognitive impairment. ClearSky’s initial studies have suggested that MCI-Monitor is able to differentiate between Parkinson’s with normal cognition, PD-MCI (Parkinson’s Disease MCI) and PDD (Parkinson’s Disease Dementia).
ClearSky is now seeking partners to collaborate on the development and launch of MCI-Monitor to the general population – learn more about MCI-Monitor. We would be delighted to welcome you to our stand.
Please do get in touch with any questions before, during or after the show.